I specialized in Biochemistry and Molecular Biology with a Master thesis on plant physiology at the University of Roma Tre (Rome, Italy). After graduating, I moved to Merck Sharp & Dohme (MSD) research laboratories (IRBM, Rome, Italy), as a Research Assistant. In 2005, I started my PhD at the University of Edinburgh (Edinburgh, UK), in Molecular Enzymology, where I gained experience in rapid kinetic assay techniques and protein crystallography. For my post-doctoral training, I moved to Helsinki University (Helsinki, Finland), where I headed a research project to discover chaperone lead compounds to target glycogen storage disease type II. In 2011, I joined IFOM, the FIRC Institute of Molecular Oncology (Milan, Italy). My current research aims at finding innovative routes in the drug discovery for leukaemia deregulated pathways, with a particular focus on TALE transcription factor (MEIS1, PREP1, and PBX1), with the aim of targeting critical interactions and designing selective molecules.